L J Hak

616 total citations
10 papers, 475 citations indexed

About

L J Hak is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, L J Hak has authored 10 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 4 papers in Public Health, Environmental and Occupational Health and 2 papers in Surgery. Recurrent topics in L J Hak's work include Acute Lymphoblastic Leukemia research (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). L J Hak is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). L J Hak collaborates with scholars based in United States. L J Hak's co-authors include Mary V. Relling, Roland N. Dickerson, R O Brown, Louis E. Underwood, W. Heizer, David R. Clemmons, William F. Finn, Brian A. Sullivan, Michael H. Woo and M Storm and has published in prestigious journals such as Gastroenterology, American Journal of Clinical Nutrition and Antimicrobial Agents and Chemotherapy.

In The Last Decade

L J Hak

10 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L J Hak United States 9 174 163 88 75 71 10 475
Richard K. Mathis United States 11 73 0.4× 42 0.3× 87 1.0× 27 0.4× 72 1.0× 23 494
JA Gaines United States 5 51 0.3× 129 0.8× 79 0.9× 54 0.7× 37 0.5× 9 421
Yashu Kuang China 16 123 0.7× 54 0.3× 94 1.1× 37 0.5× 394 5.5× 28 771
Eun Na Kim South Korea 12 93 0.5× 60 0.4× 98 1.1× 13 0.2× 161 2.3× 46 562
Kamal Hassan United Kingdom 13 56 0.3× 48 0.3× 39 0.4× 47 0.6× 58 0.8× 26 701
Mehmet Satar Türkiye 15 223 1.3× 140 0.9× 37 0.4× 15 0.2× 82 1.2× 85 695
Marcus Krüger Germany 14 61 0.4× 58 0.4× 67 0.8× 31 0.4× 42 0.6× 42 518
Ioannis A. Zervoudakis United States 11 188 1.1× 67 0.4× 24 0.3× 103 1.4× 101 1.4× 20 588
Pi‐Feng Chang Taiwan 15 214 1.2× 47 0.3× 92 1.0× 203 2.7× 206 2.9× 25 765

Countries citing papers authored by L J Hak

Since Specialization
Citations

This map shows the geographic impact of L J Hak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L J Hak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L J Hak more than expected).

Fields of papers citing papers by L J Hak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L J Hak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L J Hak. The network helps show where L J Hak may publish in the future.

Co-authorship network of co-authors of L J Hak

This figure shows the co-authorship network connecting the top 25 collaborators of L J Hak. A scholar is included among the top collaborators of L J Hak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L J Hak. L J Hak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Panetta, John C., Amar Gajjar, Nobuko Hijiya, et al.. (2009). Comparison of Native E. coli and PEG Asparaginase Pharmacokinetics and Pharmacodynamics in Pediatric Acute Lymphoblastic Leukemia. Clinical Pharmacology & Therapeutics. 86(6). 651–658. 61 indexed citations
2.
Relling, Mary V., M Storm, Michael H. Woo, et al.. (2003). Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients. Leukemia. 17(8). 1583–1588. 100 indexed citations
3.
Hak, L J, et al.. (2000). ELISA to evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemia. Journal of Immunological Methods. 239(1-2). 75–83. 23 indexed citations
5.
Dickerson, Roland N., et al.. (1997). Dose-dependent effect of octreotide on nitrogen retention and glucose homeostasis in response to endotoxemia in parenterally fed rats.. Journal of the American College of Nutrition. 16(1). 74–80. 8 indexed citations
6.
Barbhaiya, Rashmi H., C A Knupp, M Pfeffer, et al.. (1992). Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrobial Agents and Chemotherapy. 36(7). 1387–1391. 26 indexed citations
7.
Hak, L J, et al.. (1991). Pancreatitis during pentamidine therapy in patients with AIDS.. PubMed. 10(1). 56–9. 10 indexed citations
8.
Clemmons, David R., Louis E. Underwood, Roland N. Dickerson, et al.. (1985). Use of plasma somatomedin-C/insulin-like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients. American Journal of Clinical Nutrition. 41(2). 191–198. 169 indexed citations
9.
Sullivan, Brian A., L J Hak, & William F. Finn. (1985). Cyclosporine nephrotoxicity: studies in laboratory animals.. PubMed. 17(4 Suppl 1). 145–54. 65 indexed citations
10.
Hak, L J, et al.. (1982). Reversal of skin test anergy during maintenance hemodialysis by protein and calorie supplementation. American Journal of Clinical Nutrition. 36(6). 1089–1092. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026